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Abstract
microRNAs (miRNAs) are a class of highly conserved small non-coding RNAs that negatively
regulate gene expression post-transcriptionally. miRNAs are known to mediate myriad cell
processes, including proliferation, differentiation, and apoptosis. With more than 600 miRNAs
identified in humans, it is generally believed that many miRNAs function through simultaneously
inhibiting multiple regulatory mRNA targets, suggesting that miRNAs participate in regulating the
expression of many, if not all, genes. While many miRNAs are expressed ubiquitously, some are
expressed in a tissue specific manner. The muscle specific miR-1, miR-133 and miR-206 are perhaps
the most studied and best characterized miRNAs to date. Many studies demonstrate that these
miRNAs are necessary for proper skeletal and cardiac muscle development and function, and have
a profound influence on multiple myopathies, such as hypertrophy, dystrophy, and conduction
defects.
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1. Introduction
miRNAs are short (~22 nucleotide), non-coding RNA molecules that influence gene
expression, primarily post-transcriptionally. miRNAs negatively regulate gene expression
through complementary base-pair binding of the miRNA “seed sequence” (nucleotides 2–7)
to the 3′ untranslated region (UTR) of target mRNA, degrading or destabilizing the RNA
message, or inhibiting protein translation, depending on the quantity of complimentary base-
pair matches (Valencia-Sanchez, Liu, Hannon, & Parker, 2006) or the number of miRNA
targeting sites within the 3′ UTR (Sandberg, Neilson, Sarma, Sharp, & Burge, 2008).
The muscle specific miR-1 and -206 are closely related in terms of expression and function,
but differ based on chromosomal location, specific targets, and individual transcriptional
activation. In general, both miR-1, found in both skeletal and cardiac muscle, and miR-206,
specific for skeletal muscle, are shown to promote myoblast-to-myotube differentiation. By
contrast, miR-133 promotes the proliferation of myoblasts, and inhibits their differentiation.
miR-1-1 and miR-1–2 have identical mature nucleotide sequences, and miR-206 differs from
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this conserved miR-1 sequence by four nucleotides (Chen et al., 2006; Kim, Lee, Sivaprasad,
Malhotra, & Dutta, 2006; Lagos-Quintana et al., 2002; Rosenberg, Georges, Asawachaicharn,
Analau, & Tapscott, 2006). miR-133a-1 and miR-133a-2 share identical mature sequences,
with miR-133b differing from this by a single nucleotide at the 3′ end (Chen et al., 2006; Niu,
Li, Zhang, & Schwartz, 2007). The miR-1-1/miR-133a-2 and the miR-206/miR-133b clusters
are transcribed from non-coding regions on mouse chromosomes 2 and 1, respectively, while
the miR-1-2/miR-133a-1 cluster is transcribed from an intronic region of the ubiquitously
expressed E3 ubiquitin ligase gene Mib1 (Chen et al., 2006). Therefore, while these three
related clusters have similar sequences and expression patterns, each not only has distinct
targets and functions, but also must rely on their own promoters for muscle specific expression.
2. Development and Function of Cardiac and Skeletal Muscle
There are three primary muscle types; cardiac, skeletal, and smooth. All are derived from the
embryonic mesoderm in vertebrates. Muscle development is a coordinated process which
involves cellular proliferation, differentiation, migration, and cell death. Regulation of gene
expression at both transcriptional and translational levels is crucial for morphologic
development of muscle tissues. Among the three muscle types, cardiac and skeletal muscle are
striated and terminally differentiated. They are highly specific cells with the primary function
of contraction. The heart is the first functioning organ in the embryo and is developed from
lateral plate mesoderm, whereas skeletal muscle is derived from the paraxial mesoderm,
forming embryonic somites which in turn become compartmentalized into the myotome
(Buckingham, 2006; Garry & Olson, 2006).
Gene expression regulation is perhaps the most important factor governing proper
development. Studies examining gene expression during muscle development have primarily
focused on transcription factor-mediated regulation. Specifically, the family of myogenic
regulatory factors (MRFs) including MyoD, myogenin, MRF4, and Myf5, as well as the
myocyte enhancer factor 2 (MEF2) family of transcription factors are key regulators of skeletal
muscle development (Tapscott, 2005), while the GATA4, Nkx2.5, myocardin, and serum
response factor (SRF) are critical for myocardium development (Olson, 2006). Most recently,
miRNAs have emerged as another class of key regulators for muscle development (Callis &
Wang, 2008). Interestingly, many transcription factors are also affected by miRNA mediated
repression, through positive and negative feedback loops.
3. Regulation and Expression of miRNAs During Muscle Development
Whereas many miRNAs are ubiquitously expressed, some miRNAs are expressed in a tissue-
specific manner. Investigation into transcriptional regulation of miRNAs in muscle
development comes from, in part, recent studies of the miR-1 and miR-133 families. These
studies indicate that expression of miRNA genes is under transcriptional regulation, similar to
that of protein-coding genes. The bicistronic pairs of cardiac and skeletal muscle specific
miR-1-1 and miR-133a-2 (clustered on mouse chromosome 2) and miR-1-2 and miR-133a-1
(clustered on mouse chromosome 18) are regulated by SRF, MEF2, and other muscle
associated transcription factors such as GATA4 and Nkx2-5 (Chen et al., 2006; Liu et al.,
2007; Niu, Li, Zhang, & Schwartz, 2007; Zhao, Samal, & Srivastava, 2005). The bicistronic
pair of skeletal muscle specific miR-206 and miR-133b are also regulated by MEF2, MyoD,
and other factors (Kim, Lee, Sivaprasad, Malhotra, & Dutta, 2006; Rao, Kumar, Farkhondeh,
Baskerville, & Lodish, 2006; Rosenberg, Georges, Asawachaicharn, Analau, & Tapscott,
2006). MyoD and myogenin provide a common temporal regulation through the induction of
miR-1, -133, and -206 expression during myogenesis in C2C12 and human myoblast cells
(Rao, Kumar, Farkhondeh, Baskerville, & Lodish, 2006). Other studies using gain and loss of
function approaches indicate that Myf5 is both sufficient and necessary for the expression of
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miR-1 and miR-206, and that growth factors can negatively influence miRNA transcription
through MRF repression (Sweetman et al., 2008). Interestingly, these miRNAs can act to
repress there own regulators, such as SRF and histone deacetylase 4 (HDAC4), providing a
regulatory mechanism for negative feedback (Chen et al., 2006; Lu, McKinsey, Zhang, &
Olson, 2000).
4. Biological Roles of miRNA in Skeletal and Cardiac Muscle
To determine the global role of miRNAs in development, Bernstein and colleagues knocked
out Dicer in mice, preventing the processing of miRNA precursor into functional mature
molecules, and found that lethality occurs at embryonic day 7.5, with development likely
halting in gastrulation (Bernstein et al., 2003). Further examination using tissue-specific Dicer
deletion revealed that miRNAs are required for proper morphogenesis in skeletal muscle
(O’Rourke et al., 2007) and cardiac muscle (Chen et al., 2008; Zhao et al., 2007). These studies
provide convincing genetic evidences for the essential role of miRNAs in muscle development
and function. However, though the deletion of Dicer demonstrated the requirement of miRNAs
for proper development in many tissues and organs, these studies did not provide insights into
the biological functions of individual miRNAs.
Skeletal Muscle
Skeletal muscle cells develop from the embryonic mesoderm during development, where they
exist as proliferating myoblasts or terminally differentiated myotubes that have exited the cell
cycle. Overexpression and knock-down experiments using the C2C12 cell line revealed that
the roles of miR-1 and miR-206 contrast with those of miR-133 (Chen et al., 2006; Kim, Lee,
Sivaprasad, Malhotra, & Dutta, 2006). Overexpression of miR-1 or miR-206 promoted
myogenic differentiation, while miR-133 overexpression enhanced myoblast proliferation, but
represses differentiation. Knock-down assays show the converse effects on proliferation and
differentiation. miR-206 is thought to promote muscle differentiation by, in part, inhibiting a
component of DNA polymerase (Kim, Lee, Sivaprasad, Malhotra, & Dutta, 2006) as well as
follistatin-1 (Fstl1) and utrophin (Utrn), genes that are suppressed in fibroblasts converted to
skeletal muscle cells (Rosenberg, Georges, Asawachaicharn, Analau, & Tapscott, 2006).
miR-133 is also shown in C2C12 cells to repress the neuronal homologue of the polypyrimidine
tract-binding protein (nPTB), an important alternative splicing factor, during myoblast
differentiation (Boutz, Chawla, Stoilov, & Black, 2007). Misexpression of miR-206 and
miR-133a has been observed in a mouse model of muscular dystrophy (McCarthy, Esser, &
Andrade, 2007), while miR-1 and -133 have been implicated in skeletal muscle hypertrophy
(McCarthy & Esser, 2007).
Interestingly, miR-1 and miR-133, though co-expressed from the same gene, are shown to have
opposite effects on apoptosis (Xu et al., 2007) and embryonic stem cell differentiation into
cardiomyocytes (Ivey et al., 2008). Targeting predictions, as well as experimental evidences,
suggest a negative regulatory feedback mechanism that may help explain the contrasting affects
of miR-1 and miR-206 with those of miR-133. Our lab observed that miR-1 repressed HDAC4,
which in turn represses MEF2, contributing to the increase of differentiated myotubes during
miR-1 overexpression. The same study showed that miR-133 repressed SRF, therefore leading
to increased myoblast proliferation (Chen et al., 2006), and this has been reinforced by other
studies (Niu, Li, Zhang, & Schwartz, 2007). This regulatory feedback mechanism may
contribute to the specificity and regulation of muscle cell proliferation and differentiation
during development.
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Cardiac development depends on an intricate coordination of different cell types. As the heart
is the first organ to develop in the embryo, strict regulation is essential at critical temporal
points. Cardiac specific deletion of Dicer, using a Cre-recombinase driven by the alpha myosin
heavy chain (αMHC) promoter, which is expressed in the atria at embryonic day (ED) 8 and
in both the ventricles and atria at birth, leads to early postnatal lethality in mice. Mutant hearts
displayed dilated cardiomyopathy with cardiomyocyte sarcomeres affected (Chen et al.,
2008). Conversely, early cardiac deletion of Dicer using an Nkx2–5 driven Cre-recombinase,
which is expressed as early as ED 7.5, resulted in embryonic lethality and developmental heart
defects (Zhao et al., 2007). Together, these studies demonstrate an essential role of miRNAs
in proper heart development and function.
Studies in both Drosophila (Kwon, Han, Olson, & Srivastava, 2005; Sokol & Ambros, 2005)
and mice (Zhao, Samal, & Srivastava, 2005) demonstrated the importance of miR-1 (dmiR-1
in Drosophila) during cardiogenesis. Specifically, flies lacking dmiR-1 displayed a loss of
differentiation in some (but not all) muscle, and this dmiR-1 deletion resulted in pools of
undifferentiated progenitor cells. Conversely, dmiR-1 overexpression disrupted cardioblast
patterning in fractions of embryos. The delta/Notch signaling pathway is proposed to mediate
the morphologic consequences of dmiR-1 in Drosophila. Similar to these results, it was
demonstrated that overexpression of miR-1 in mouse hearts causes a decrease of ventricular
cardiomyocyte pools through, in part, the targeting of Hand2, ultimately leading to heart failure
(Zhao, Samal, & Srivastava, 2005). In the absence of miR-1-2, mouse hearts became
hyperplastic, indicating a role for miR-1-2 in negatively regulating proliferation in
cardiogenesis. Mutant cardiomyocytes also underwent karyokinesis, indicative of cell cycle
dysregulation. These mice also displayed ventricular septal defects (VSDs), possibly due to
the subsequent upregulation of the Notch signaling mediator Hrt2/Hey2, and the bHLH
transcription factors Hand 1 and 2 (Zhao et al., 2007).
In support of studies using mice and flies, injections of miR-1 into Xenopus laevis embryos at
the one-cell stage resulted in abnormal cardiac development and decreased cell proliferation.
Similar injections of miR-133 resulted in a highly disorganized heart, absent of any cardiac
looping or chamber formation, as well as an increase in cell proliferation (Chen et al., 2006).
Recent genetic studies in mice further demonstrate the essential role of miR-133a in
cardiomyocyte proliferation and heart development (Liu et al., 2008).
In addition, cardiac conduction defects have been observed in recent studies of miR-1 and
miR-133. When overexpressed in rat hearts, miR-1 appears to diminish conduction, leading to
arrhythmias, apparently through repression of the potassium channel subunit Kcnj2 and the
gap junction protein connexin 43 (Yang et al., 2007). miR-1–2 has also been shown to directly
target Irx5, a repressor of the potassium channel Kcnd2, leading to increased arrhythmias
(Zhao et al., 2007). In a rabbit model of diabetes (Xiao et al., 2007), it was reported that the
cardiac potassium ion channel protein ether-a-go-go (ERG) was repressed in mice
overexpressing miR-133, leading to slower repolarization and QT prolongation, resulting in
cardiac arrhythmia.
5. Medical Significance
As the characterization of specific miRNAs has increased exponentially in recent years,
miRNAs have been implicated in a vast array of diseases, ranging from cancer to cardiovascular
disorders. Many recent studies have documented dysregulation and abnormal expression of
miRNAs in human patients and/or animal models for human disease. Given that miRNAs are
also evolutionary conserved, a picture has emerged which points to a fundamental requirement
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of miRNAs in cardiac and skeletal muscle development and function, implying their potential
involvement in muscle-related disease.
In 2008, our lab reported a correlation between Dicer protein levels and cardiac disease in
human patients. In hearts failing from dilated cardiomyopathy, Dicer protein levels were very
low when compared to non-failing hearts. Interestingly, when the same patients were fitted
with a left ventricular assist device (LVAD), a device used to provide mechanical support for
end-stage failing hearts, Dicer levels rebounded to levels comparable with non-failing hearts
(Chen et al., 2008).
miR-1 and miR-133 have been implicated in cardiac muscle remodeling and their expression
is dysregulated during cardiac hypertrophy and heart failure (Care et al., 2007; Sayed, Hong,
Chen, Lypowy, & Abdellatif, 2007; Tatsuguchi et al., 2007). In mice, miR-1 is downregulated
immediately following surgically induced cardiac hypertrophy, suggesting a role in cardiac
remodeling. (Sayed, Hong, Chen, Lypowy, & Abdellatif, 2007). Interestingly, miR-133
suppression was reported to induce hypertrophy in mice by directly targeting RhoA, Cdc42,
and Nelf-A/WHSC2 (Care et al., 2007). This paradox of both miR-1 and -133 perhaps sharing
a similar function in cardiac hypertrophy underscores the complexity of miRNA targeting
events that ultimately lead to biological function.
Taken with the previously mentioned studies examining miRNAs in models of muscular
dystrophy (McCarthy, Esser, & Andrade, 2007), diabetes (Xiao et al., 2007), and cardiac
arrhythmias (Xiao et al., 2007; Yang et al., 2007; Zhao et al., 2007), it is clear that miRNAs
can have profound influence by specifically regulating multiple targets that coordinate within
a common biological function, maintaining the homeostasis required for normal processes
(Leung & Sharp, 2007). We predict that miRNAs will have therapeutic potential either by being
used to target specific genes, or by becoming therapeutic targets themselves.
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Figure 1. Regulation and function of muscle specific miRNAs
Cardiac and skeletal transcription factors GATA4, Nkx2.5, myocardin, SRF, MEF2, and other
myogenic regulatory factors (MRFs) regulate the expression of miR-1/133/206 polycistronic
loci. The subsequent transcription of miR-1 promotes myocyte differentiation through the
repression of HDAC4, which in turn represses MEF2. miR-133 promotes myocyte proliferation
by repressing SRF. Thus, a feedback loop is created in which miR-1 and miR-133 and their
respective transcription factors regulate each others expression.
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TABLE 1
miRNAs 1, 133, and 206 in cardiac and skeletal muscle development and disease.
microRNA Expression Pattern Biological Roles Validated Targets References









(Chen et al., 2006; Kwon, Han, Olson, & Srivastava,
2005; Sokol & Ambros, 2005; Tatsuguchi et al., 2007)






(Care et al., 2007; Chen et al., 2006; Kwon, Han, Olson,
& Srivastava, 2005; Sokol & Ambros, 2005; Tatsuguchi
et al., 2007)
miR-206 Skeletal Muscle Myogenesis Fstl1, Pola1, Utrn (Kim, Lee, Sivaprasad, Malhotra, & Dutta, 2006;
Rosenberg, Georges, Asawachaicharn, Analau, &
Tapscott, 2006)
Abbreviations: Hand2, Heart and neural crest derivatives expressed 2; HDAC4, Histone deacetylase 4; Hsp60, heat-shock protein 60; Hsp70, heat-
shock protein 70; RasGAP, Ras GTPase-activating protein; RhoA, Ras homolog A; SRF, Serum response factor; Fstl1, follistatin 1; Utrn, utrophin.
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